search for




 

https://doi.org/10.3938/NPSM.69.215
Evaluation of Proton-Boron Fusion-Enhanced Proton Therapy (PBFEPT) by Using a Simulation Method
New Phys.: Sae Mulli 2019; 69: 215~220
Published online February 28, 2019;  https://doi.org/10.3938/NPSM.69.215
© 2019 New Physics: Sae Mulli.

Dong LIU1, Sue Lynn LEE2, Jong-Kwan WO*3

1 BK21plus Clean Energy Convergence and Integration Center for Human Resources Training and Education, Jeju National University, Jeju 63243, Korea 

2 Division of Engineering, Cambridge University, Cambridgeshire, England

3 Department of Physics, Jeju National University, Jeju 63243, Korea

Correspondence to: w00jk@jejunu.ac.kr
Received September 11, 2018; Revised October 25, 2018; Accepted October 29, 2018.
cc This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Radiation therapy is a technique for delivering sufficiently high doses to target cells while keeping the dose to neighboring normal tissues as low as possible. As an advanced radiation therapy method, proton therapy has a more ideal dose distribution than either electron or photon therapy due to the Bragg peak. Recently, an enhanced proton therapy based on the proton-boron ($^{11}$B) fusion reaction was proposed. For this method, alpha emitters from proton-boron fusion reactions are utilized to improve the dose deposition in the target. A few studies have confirmed this method by using the Monte Carlo N-Particle (MCNP) code. In our study, a mathematical method and the GEometry ANd Tracking (GEANT4) toolkit are combined to evaluate and analyze the dose distribution of the proton-boron ($^{11}$B) fusion-enhanced proton therapy (PBFEPT) method. Calculations of both the emitters of proton-boron ($^{11}$B) fusion reactions based on related cross-sections and the dose distribution of alpha emitters by using Geant4 toolkit, PBFEPT is found relatively to enhance the dose deposition in the target volume. This results agrees with those of previous studies.
PACS numbers: 42.62.Be, 29.25.-t
Keywords: Proton therapy, Proton-boron ($^{11}$B) fusion-enhanced proton therapy (PBFEPT), Monte Carlo method


February 2019, 69 (2)
  • Scopus
  • CrossMark